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ABSTRACT: Serotonin (5-hydroxytryptamine, 5-HT) is a prevalent neuro-
transmitter throughout the animal kingdom. It exerts its eﬀect through the
speciﬁc binding to the serotonin receptor, but recent research has suggested
that neural transmission may also be aﬀected by its nonspeciﬁc interactions
with the lipid matrix of the synaptic membrane. However, membrane−5-HT
interactions remain controversial and superﬁcially investigated. Fundamental
knowledge of this interaction appears vital in discussions of putative roles of 5-
HT, and we have addressed this by thermodynamic measurements and
molecular dynamics (MD) simulations. 5-HT was found to interact strongly
with lipid bilayers (partitioning coeﬃcient ∼1200 in mole fraction units), and
this is highly unusual for a hydrophilic solute like 5-HT which has a bulk, oil−
water partitioning coeﬃcient well below unity. It follows that membrane
aﬃnity must rely on speciﬁc interactions, and the MD simulations identiﬁed
the salt-bridge between the primary amine of 5-HT and the lipid phosphate group as the most important interaction. This
interaction anchored cationic 5-HT in the membrane interface with the aromatic ring system pointing inward and a prevailing
residence between the phosphate and the carbonyl groups of the lipid. The unprotonated form of 5-HT shows the opposite
orientation, with the primary amine pointing toward the membrane core. Partitioning of 5-HT was found to decrease lipid chain
order. These distinctive interactions of 5-HT and model membranes could be related to nonspeciﬁc eﬀects of this
neurotransmitter.
■ INTRODUCTION
Knowledge of the interaction of small molecules with lipid
membranes and their bilayer distribution is of great
pharmacological importance and represents an active ﬁeld of
current biophysical research.1 Pharmacologically active mole-
cules (drugs) are often targeting transmembrane proteins, and
it has been proposed that the plasma membrane can serve as a
reservoir for small molecules and thereby facilitate binding of
these molecules to the target protein.2 The underlying
mechanism is that interfacial binding to or partitioning into
the membrane will bring the drug molecule in close proximity
to its target, and consequently, the interaction probability
between drug molecule and target transmembrane protein will
increase.2 The plasma membrane has also been proposed as a
primary target for general anesthetics. Their action may rely on
direct binding to postsynaptic ligand-gated ion channels
(LGICs) or an indirect eﬀect, mediated through absorption
into the postsynaptic bilayer membrane.3−6 Recently, the
crystal structures of complexes of the anesthetics propofol and
desﬂurane with bacterial Gloeobacter violaceus pentameric LGIC
have been solved.3 These structures revealed a general-
anesthetic cavity, which is accessible from the lipid bilayer.
Propofol was found to bind at the entrance of the cavity,
whereas the smaller, more ﬂexible desﬂurane binds deeper
inside. Conversely, indirect eﬀects of anesthetic partitioning will
alter the biophysical properties of the bilayer and thus aﬀect the
function of the LGICs.5,7−9 The best documented nonspeciﬁc
lipid−protein interactions are based on so-called lipid−protein
hydrophobic mismatch,10,11 i.e., a mismatch between the
hydrophobic length of the protein and the hydrocarbon
thickness of the surrounding lipid bilayer. These protein−
bilayer hydrophobic interactions may cause lipid packing stress,
and protein function modulation could result from coupling
protein conformational changes to elastic deformations of the
surrounding bilayer membrane.11,12 This has been experimen-
tally observed for γ-aminobutyric acid type A (GABAA),
glycine, and N-methyl-D-aspartate (NMDA) receptors, where
their function can be modulated by membrane-active
amphiphiles such as surfactants, Triton-X, benzodiazepines,
barbiturates, long-chain alcohols, and anesthetics.12−14 Sonner
and co-workers provided evidence that LGICs’ function can be
modulated by co-released neurotransmitters in a fashion similar
to that observed for anesthetics.15 The authors studied the
inhibitory glycine and GABAA receptors and the excitatory
NMDA receptor and showed that NMDA receptor function is
inhibited by acetylcholine, whereas glycine and GABAA
receptor function is enhanced by respectively γ-aminobutyric
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acid and glycine. The authors suggest an anesthetic-like
mechanism of neurotransmitters, where the molecules modu-
late bilayer properties. LGIC receptors are adapted to these
changes and use them to regulate their conformational
equilibrium. Moreover, a membrane-mediated mechanism has
also been suggested for polyhydric alkanols that exhibit
anesthetic potency in tadpoles.16
These studies indicated that, beyond binding of the
neurotransmitters to their LGIC receptors, the receptor can
also be modulated indirectly by changes in membrane
properties. Clearly, these two mechanisms may not be
exclusive, and depending on LGIC receptor, both mechanisms
may contribute to the physiological action of the neuro-
transmitter. Experimental studies of the thermodynamics and
membrane partitioning of neurotransmitters are limited.17,18
Due to the complex nature of a biological membrane and its
lipid−water interface, simple partition experiments in water/
octanol biphasic systems do not provide information on the
distribution of a molecule in the inhomogeneous bilayer
environment or its eﬀect on lipid properties. More structure-
based biophysical methods are required to understand the
interactions of small molecules with membrane interfaces.
Molecular dynamics (MD) simulations are a powerful tool to
provide insight on the molecular scale,19−21 and the technique
has been used extensively to study a wide range of solutes and
their interactions with diﬀerent kinds of lipid membranes.22−29
In the present study, MD simulations in combination with
thermodynamic measurements are applied to study the
interaction of 5-HT with phosphocholine (PC) bilayer
membranes. Our results show that serotonin interacts strongly
with PC bilayers. The charged primary amine group interacts
predominately with the PC phosphate group. This interaction
serves as an anchor, placing the primary amine group in the
interfacial plane and the aromatic ring system into the bilayer.
5-HT is not able to cross the bilayer membrane mainly due to
two contributions: the aliphatic amino group in 5-HT acts as an
anchor to the interfacial bilayer plane, and the ﬂexibility of the
phospholipid alkyl chain tails provides an entropic barrier for
serotonin to cross the center of the bilayer membrane.
■ EXPERIMENTAL AND COMPUTATIONAL
PROCEDURES
Simulations. MD simulations were performed for a single
serotonin (5-hydroxytryptamine, 5-HT; Figure 4) molecule together
with a phospholipid bilayer consisting of pure 1,2-dipalmitoyl-sn-
glycero-3-phosphocholine (DPPC) or pure 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC). 5-HT has two pH-sensitive groups (see
Figure 4): the aliphatic amino group (N22) and the aromatic hydroxyl
moiety (O4).30,31 Since the primary amino group has pKa = 9.97, we
have considered both the charged and neutral forms of serotonin
(hereafter named 5-HT+ and 5-HTn, respectively). The bilayers
consisted of 72 phospholipid molecules (36 per leaﬂet), fully hydrated
with 3319 water molecules (∼46 water molecules per lipid molecule),
and the center of mass of the bilayer was located at x = y = z = 0 Å,
with z being the direction normal to the bilayer plane. The DOPC
bilayer was constructed from a DPPC bilayer. We conducted three
simulations (each ∼120 ns) for DOPC/5-HT+, four simulations (each
70−80 ns) for DPPC/5-HT+, and four simulations (each 60−70 ns)
for DPPC/5-HTn. The ﬁrst 5 and 20 ns of respectively each DPPC/5-
HT+,n and DOPC/5-HT+ simulation (corresponding to the equilibra-
tion of the area/lipid molecule) were discarded from further analyses.
In comparison to DOPC, shorter simulations were required for
DPPC/5-HT+,n, since the initial conﬁguration of the DPPC bilayer
membrane was taken from a previous study.32 The initial position of
the serotonin molecule was chosen such that the molecule was placed
at diﬀerent distances away from the interfacial plane of the bilayer
membrane using the VMD 1.8.7 software package.33 Water molecules
that were within 2.4 Å of the serotonin molecule were deleted using
VMD. To neutralize the charged systems DPPC/5-HT+ and DOPC/
5-HT+, one water molecule in each system was randomly picked and
replaced with a chloride ion. The force ﬁeld parameters, including
partial charges for 5-HT+, were adapted from a previous study.34,35
The partial charges of the primary amine group of 5-HTn were taken
from the lysine residue force ﬁeld parameters given by the
CHARMM27 force ﬁeld.36 Simulations were performed using the
NAMD 2.5 software package with a modiﬁed CHARMM27 force ﬁeld
for DPPC and the TIP3P water model.32,37,38 We previously re-
parametrized the force ﬁeld for the DPPC headgroup region based on
the experimental data from Nagle and co-workers.39 We used the same
parameters for the DOPC bilayer. Simulations were carried out in the
NPT ensemble at constant pressure (P = 1 atm) and temperature (T =
323 K for DPPC and T = 303 K for DOPC system), applying periodic
boundary conditions and using the particle mesh Ewald method for
calculating the long-range electrostatic forces.40 Simulations were
carried out using parameters described previously32,41 and listed in the
Supporting Information. In addition to these simulations, we
conducted simulations with umbrella sampling and used the weighted
histogram analysis method (WHAM) to assess the potential of mean
force (PMF) along the bilayer normal.42−45 These procedures are also
described in more detail in the Supporting Information.
Materials. Serotonin hydrochloride (5-HT) (>98%, powder,
Sigma-Aldrich), 1,2-dimyristoyl-sn-glycero-3-phosphocholine
(DMPC), and DOPC (99%, power, Avanti Polar Lipids) were used
as received.
Preparation Unilamellar Vesicles. DMPC or DOPC was
hydrated with freshly prepared Milli-Q water to give multilamellar
vesicles (MLVs) with a concentration about 2% (w/w). The MLVs
were further hydrated and then extruded into 100 nm unilamellar
vesicles (ULVs) as described previously.18,46 The ﬁnal lipid
concentration was measured gravimetrically to within ±0.02%.47 The
choice of DMPC membranes for the experiments and DPPC
membranes in the simulations was based on technical restrictions:
the dialysis equipment cannot operate at the higher main transition
temperature of DPPC. It has previously been shown in MD
simulations that DMPC and DPPC have many common features,
resulting in indistinguishable interfacial properties.48 Moreover, the
interaction of 5-HT with the two types of lipids appears to be
equivalent inasmuch as the change in DMPC transition temperature
found here (Figure 1) is equivalent to that previously reported for 5-
HT/DPPC.49 Therefore, a direct comparison of DMPC and DPPC
appears to be reasonable.
Dialysis and HPLC. The aﬃnity of serotonin for lipids (DMPC or
DOPC) was assessed by dialysis equilibrium measurements as
described elsewhere.46,50 The equilibrium, molal concentration of 5-
HT inside and outside the dialysis bag (inm5‑HT and
outm5‑HT,
respectively), and lipid concentration inside the dialysis bag were
measured by HPLC (Varian 9012, Santa Clara, CA) equipped with an
evaporative light scattering detector (Sedex85, Sedere, France), UV
detector (Varian 9050), and an Aquity C18 column. The eluent was
methanol:1-propanol:water (6:4:1), which completely dissolved the
vesicles during the analysis. The diﬀerence in serotonin concentration
across the dialysis membrane (Δm5‑HT) in molal units (i.e., mol per kg
water) was calculated according to Δm5‑HT = inm5‑HT − outm5‑HT. The
outside concentration, outm5‑HT, was derived directly from the raw
HPLC data and an appropriate standard curve. Samples from inside
the bag contained both aqueous solution and (∼2%) lipid, and the raw
HPLC signal was divided by (1 − w2), where w2 is the weight fraction
of lipid, to obtain the 5-HT concentration in molal units.46,50
Diﬀerential Scanning Calorimetry (DSC). The eﬀect of
serotonin on the phase behavior of DMPC was measured on a
Nano-Diﬀerential Scanning Calorimeter III (TA Instruments, New
Castle, DE). The samples were prepared volumetrically from a stock
DMPC (ULV) and stock serotonin solution to always give the same
concentration of DMPC (3.8 mmol/kg H2O). Transmembrane
equilibration of 5-HT was obtained through temperature cycling
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around the main transition temperature. Degassed sample (serotonin
and DMPC) and reference (aqueous serotonin) solutions were loaded
into the DSC and heated at 0.1 °C/min from 12 to 32 °C. Three scans
were performed on each sample. The uncertainty in the maximum of
the transition peak was 0.02 °C.
■ RESULTS AND DISCUSSION
Experiments. Two issues appear critical in the discussion of
the membrane matrix as a putative target for 5-HT: (i) what is
the net aﬃnity of 5-HT for lipid membranes (i.e., does it
partition into the membrane or not), and (ii) is membrane
partitioning (if any) driven by hydrophobic eﬀects, or does 5-
HT make favorable polar contacts with moieties of the
phospholipid molecules? With respect to question (i), we
used dialysis equilibrium measurements to provide a model-free
measure of the net aﬃnity.
Results in Figure 1 show that the concentration diﬀerence,
Δm5‑HT (see Experimental and Computational Procedures),
was consistently positive, and this speciﬁes attractive inter-
actions. For DMPC (in both the gel and ﬂuid states), the
increase in Δm5‑HT was nearly proportional to the free
(aqueous) 5-HT concentration, outm5‑HT, and this behavior is
in line with a conventional partitioning picture. The
partitioning coeﬃcient in molal concentration units, Kp,m =
memm5‑HT/
aqm5‑HT, where superscripts “mem” and “aq” signify
the membrane and aqueous bulk, respectively, can be calculated
from the data in Figure 1. Thus, the molal concentration of 5-
HT in the membrane (i.e., mmol of 5-HT partitioned per kg
lipid) is memm5‑HT = Rw:lΔm5‑HT, where Rw:l is the water:lipid
mass ratio in the dialysis bag. For DMPC, the Kp,m values were
respectively 32 ± 2 (ﬂuid phase, 30 °C) and 12 ± 4 (gel phase,
18 °C). In mole fraction units, this translates into coeﬃcients
(Kp,x) of respectively 1.2 × 10
3 and 4.4 × 102. For DOPC, the
results in Figure 1 show positive curvature, which implies that
the aﬃnity for 5-HT rises as the membrane is increasingly
perturbed by the solute. We do not have data to elucidate the
origin of this behavior, but note that in the lower part of the
concentration range investigated here (<∼0.3 mmol/kg water)
the aﬃnity of 5-HT for DOPC is comparable to that for
DMPC. Earlier reports on the net aﬃnity of 5-HT for lipid
bilayers are divisive. Fluorescence measurements suggested no
signiﬁcant binding or partitioning to membranes composed of
either POPC or POPC/POPG mixtures.51 Other works found
that 5-HT lowered the main transition temperature, Tm, of
saturated PC, and ascribed this to an interaction.49,52 We
conducted DSC measurements on DMPC and found a clear
reduction in Tm (inset of Figure 1), even for the sub-millimolal
5-HT concentrations used here. This is qualitatively in line with
the dialysis results, as a stronger interaction with the ﬂuid
membrane (ﬁlled circles in Figure 1) will favor this state over
the gel (open circles) and hence lower the transition
temperature. The calorimetric data may be analyzed
quantitatively if we apply a solid solution freezing point
depression model.53 As shown in the Supporting Information,
the initial slope in the inset of Figure 1 translates into a Kp,x
value of about 700 for ﬂuid DMPC. This value is based on a
number of approximations and cannot be considered accurate
(see Supporting Information), but its order of magnitude
corresponds to the (more precise) result from the dialysis
measurement, and the DSC measurements thus support the
conclusion that 5-HT interacts strongly with the bilayers. The
interaction of 5-HT is strong compared to those of other small,
cyclic compounds such as benzyl alcohol and cyclohexanol,
which have Kp,x values of 300−400 for ﬂuid DMPC.
54 The
extent of partitioning for 5-HT is comparable to that of highly
hydrophobic compounds such as 1-hexanol (Kp,x ≈ 8−900) or
1-heptanol (Kp,x ≈ 2−4000).55,56 For these latter molecules, the
membrane partitioning coeﬃcients are similar to bulk (“oil−
water”) partitioning coeﬃcients,57,58 and this suggests that
partitioning is essentially driven by a hydrophobic expulsion
from the aqueous phase, while direct interactions in the
membrane are less important.59,60 This is in strong contrast to
5-HT, which has a bulk partitioning coeﬃcient about 3 orders
of magnitude lower49,61,62 than the values found here for ﬂuid
PC bilayers. Most recently, Tatsumi and Ueda63 used precise
electrochemical methods to show that the partitioning
coeﬃcient between water and nitrobenzene for the cationic
form of 5-HT (which dominates at neutral pH) was as low as
0.007. We conclude that 5-HT interacts strongly with PC
membranes, and in light of its hydrophilic nature (manifested in
low bulk partitioning), the aﬃnity must involve strong contact
interactions with the lipid (cf. question (ii) above). Although
some aﬃnity for lipid membranes has been found for other
polar neurotransmitters,18 the strength of the PC-5-HT
interaction appears unusual for a hydrophilic compound.
Below, we investigate this by MD simulations.
Simulations. Simulations of pure DPPC and DOPC
bilayers (i.e., with no 5-HT) showed surface areas and order
parameter proﬁles (Figures S1, S2, Supporting Information) in
good accordance with previously reported simulation results
and experimental values.32,64−70 These tests are described in
some detail in the Supporting Information. Here, we are
interested in the eﬀects of adding 5-HT, and we ﬁrst note that
5-HT contains a primary amino group (N22) and an aromatic
hydroxyl moiety (O4) (cf. Figure 4), with pKa values of
respectively 9.97 and 10.73.30,31 Hence, 5-HT is cationic
around neutral pH.63 However, the low dielectric constant
environment inside the membrane could favor the neutral form
of 5-HT. Shifts in pKa in response to local environments are
well documented71−73 and seen for example for oleic acid,
which increases pKa from 5 to 7.6 upon transfer from water to a
phosphatidylcholine membrane.74 We therefore studied the
Figure 1. Main panel: results from dialysis equilibrium measurements.
The concentration diﬀerence, Δm5‑HT (see Experimental and
Computational Procedures), is plotted as a function of the bulk 5-
HT concentration, measured in the reservoir outside the dialysis bag.
Positive values of Δm5‑HT specify attractive membrane−serotonin
interactions. Inset: eﬀect of 5-HT on the main transition temperature
of DMPC measured by DSC. The abscissa in the inset is the total
(bound + aqueous) 5-HT concentration.
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interactions of both the charged (5-HT+) and neutral (5-HTn)
forms of serotonin with DPPC. To investigate the interfacial
behavior of serotonin in unsaturated lipid bilayers, we also
considered the DOPC/5-HT+ system.
Serotonin−Bilayer Interactions. The structural properties of
the bilayers and the absorption behavior of 5-HT were
extracted from the positional probability distributions of
selected atoms of the phospholipids, the hydroxyl oxygen
atom in 5-HT (O45‑HT) and the oxygen atom in water (W).
The selected lipid atoms are the phosphorus atom (Plipid) in the
phosphate group, the nitrogen (Nlipid) in the choline group, the
carbonyl carbon of the ester group (C1lipid, glycerol backbone),
and the methyl group (C16/C18, tail).The atoms chosen are
displayed in Figures 2 and 3 for phospholipid and in Figure 4
for 5-HT. The proﬁles are shown in Figures 2 and 3 for
respectively DPPC/5-HT+,n and DOPC/5-HT+.
The proﬁles for the phospholipid atoms and water molecules
resemble similar features that are generally observed in PC
bilayers, i.e., penetration of water molecules into the lipid
headgroup region, broad Plipid and Nlipid proﬁles with a full
width at half-maximum ∼8 Å, and ﬂexible lipid tails (cf. refs 75,
76). Interestingly, both 5-HT+ and 5-HTn are able to enter the
bilayer membrane independently of the saturation of the
phospholipids. The highest probability for observing 5-HT is in
the headgroup region, that is, between the glycerol backbone
(C1lipid) and the choline (Nlipid) group. The 5-HT proﬁles are
relatively broad, reﬂecting the mobility of 5-HT in the bilayer.
There is a clear diﬀerence in the distributions of 5-HT+ when
compared to 5-HTn (Figure 2), and when the results for
DPPC/5-HT+ and DOPC/5-HT+ are compared. In DPPC, the
neutral species penetrate on average deeper into the bilayer
than 5-HT+. For DOPC, the 5-HT+ proﬁle is broader (Figure
3), with a weak tendency to show two maxima. This tendency is
also indicated in the PMF data (Figure S6). Notably, there is a
higher probability of 5-HT+ to enter deeper into the DPPC
bilayer membrane than observed for the DOPC bilayer (0.11 vs
0.04 at z ∼10 Å).
This is further supported by Figure 4, where we have plotted
the ratio N225‑HT(z)/O45‑HT(z) as a function of O45‑HT(z) for
DPPC/5-HT+,n. Similar results were observed for DOPC/5-
HT+ (data not shown).
N225‑HT(z) and O45‑HT(z) are respectively the hydroxyl
oxygen position and the aliphatic amino group position along
the bilayer normal. Proﬁles for O45‑HT(z) as a function
N225‑HT(z) are provided in Figures S3 and S4 (Supporting
Information) for respectively DPPC/5-HT+,n and DOPC/5-
HT+. The positional probability distribution, Plipid(z), is also
included as a reference in Figure 4, and the horizontal dotted
Figure 2. Positional probability distribution for selected groups along
the bilayer normal, z, averaged over the last ∼70 ns of each MD
trajectory and over the multiple trajectories of either DPPC/5-HT+ or
DPPC/5-HTn simulations. Proﬁles for the phospholipid atom Plipid
(phosphate group), Nlipid (choline group), C1lipid (carbonyl carbon of
glycerol backbone), and C16lipid (carbon in the methyl group, tail) are
shown along with the proﬁles for water molecules (Wwater) and O45‑HT
(oxygen of the hydroxyl group of 5-HT). Error bars represent SEM for
the four independent simulations. The center of mass of the bilayer is
located at z = 0. Phospholipid and neurotransmitter structures
showing the atom types are displayed in the insets of Figures 2 and 4,
respectively.
Figure 3. Positional probability distribution for selected groups along
the bilayer normal, z, averaged over the last ∼100 ns of each MD
trajectory and over the multiple trajectories of DOPC/5-HT+
simulations. C18lipid corresponds to the methyl group of the lipid
fatty acid chain (tail); error bars and other groups are speciﬁed in
Figure 2.
Figure 4. Scatter plot of the ratio of N225‑HT(z) and O45‑HT(z)
position as a function of O45‑HT(z) position. The z-axis is along the
bilayer normal, and the center of mass of the bilayer is located at z = 0.
Black, DPPC/5-HTn; green, DPPC/5-HT+. As a reference, the
probability distribution, Plipid, is included (see Figure 2 for details).
Plipid is scaled by a factor of 20 (y-axis) to show it on the same plot.
The graph speciﬁes the orientation of 5-HT and schematically shows
the speciﬁc interactions observed between lipid and 5-HT. In the water
phase, free orientation is observed, whereas depending on the
protonation state of 5-HT, two distinct orientations of 5-HT are
seen. Top: 5-HT+; primary amino group points to the bilayer water
interface. Key interaction: Plipid−N225‑HT. Bottom: 5-HTn; primary
amino group points into the bilayer region. Key interaction: Plipid−
H55‑HT.
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line in the ﬁgure corresponds to an orientation of 5-HT where
O45‑HT(z) and N225‑HT(z) would be at the same z-position. In
the water phase, an evenly distributed band around the dashed
line is observed, indicating 5-HT can freely rotate (see also
Figures S3 and S4). 5-HT orientation becomes restricted only
when 5-HT enters the interfacial region and reaches the
glycerol backbone (corresponding to the maximum in C1lipid;
Figure 2). Here, 5-HT+ favors an orientation where the charged
primary amino group points to the bilayer water interface
(Figure 4, top). In contrast, for 5-HTn, the aliphatic amino
group points to the center of the bilayer (Figure 4, bottom),
and the hydroxyl group (H5−O4) points to the interfacial
bilayer plane. It appears that, due to the loss of the charge on
N225‑HT, it is energetically more favorable to align the carbon
chain of 5-HTn with the phospholipid alkyl chain. To test
whether this opposite orientation of respectively 5-HTn and 5-
HT+ could be related to poor convergence, we conducted a
simulation where the charge status of N225‑HT was changed
intermittently. The results (Figure S7) conﬁrmed the charge-
dependent turnover of 5-HT and suggested that relaxation to
the preferred orientation could be captured in simulations of
the current length. For the charged 5-HT species and
independent of the saturation of the phospholipids, the
interactions between the charged N225‑HT group and (as
discussed below) the phosphate group are strong enough to
force the aromatic ring system into the alkyl chain part of the
phospholipids. Clearly, for the 5-HT orientation, there is a
balance between electrostatic interactions (charged species)
and entropic contribution (neutral species). The positional
probability distributions for 5-HT also overlap with the
distributions of the phospholipid methyl groups (tails) (Figures
2 and 3). Hence, two contributions may prevent deeper
penetration of serotonin into the bilayer: ﬁrst, the favorable
interactions of the aliphatic amino group with the phosphate
group and second, the ﬂexibility of the methyl group. Taken
together with the experimental data (Figure 1), this suggests
that 5-HT is characterized by a high partitioning but low
permeability, and this is unusual for a small solute. This picture
is further supported by the simulations with umbrella sampling.
Thus, the PMF data in Figure S6 show a large free energy
barrier for membrane permeation and a minimum for the
center of mass of 5-HT+ in the z = 12−16 Å range. This
preferred depth compares favorably with the maximum
probability of O4 around z = 10−13 Å found in Figures 2
and 3 (the diﬀerence in the two approaches simply reﬂects the
distance (∼3.6 Å) between the center of mass and O4). The
PMF analysis suggests a free energy change for the bulk-
membrane transfer of 5-HT of −10 to −15 kJ/mol, and this is
in reasonable accordance with the experimental result, ΔG° =
−RT ln Kp,m = −9.0 ± 0.4 kJ/mol.
To further quantify key interactions between lipid and
neurotransmitter, we determined the minimum distance (dmin)
between selected phospholipids and 5-HT atoms along the
trajectories and calculated the probability distribution functions,
P(dmin). The most important P(dmin)’s are between Plipid, Nlipid
and N125‑HT, N225‑HT, H55‑HT. Location of the atoms in the
lipid and 5-HT structure are shown in Figures 2 and 4,
respectively. P(dmin) values for Plipid-5-HT and Nlipid-5-HT are
displayed in Figure 5 and Figure S5, respectively, for DPPC/5-
HT+ (left), DOPC/5-HT+ (middle), and DPPC/5-HTn (right).
In Figure 5, only a narrow range of dmin is displayed to
emphasize the diﬀerence in interactions. Corresponding
P(dmin)’ for 2 Å ≤ dmin ≤ 9 Å are provided in Figure S5. For
the charged 5-HT species, the most important interaction is
between Plipid and N225‑HT, followed by Plipid-H55‑HT. It appears
that the Plipid-N225‑HT interaction is important for both
attracting and anchoring the charged serotonin molecule to
the membrane (schematically shown in Figure 4). Plipid-N125‑HT
interaction plays only a minor role, since the P(dmin)s are
relatively broad, indicating that N125‑HT interacts only weakly
with the polar phospholipid atoms. In contrast, for 5-HTn
lacking the positive charge, only Plipid-H55‑HT interaction
becomes signiﬁcant. This is expected, since the 5-HTn
orientation is opposite to 5-HT+ (schematically shown in
Figure 4). Diﬀerent interaction patterns are observed for the
choline group with 5-HT (Figure S5). Only interactions
between the choline group and N125‑HT and to a lesser extent
H55‑HT play a role. However, these distributions are relatively
broad, indicating again that these atoms interact only weakly
with the choline group. Hence, interactions of the phosphate
group and the cationic amine are the dominating contributions
for attracting and anchoring the charged species of 5-HT.
Despite the dominant role of ionic Plipid-N225‑HT contacts, this
interaction is not long lived. Thus, if 5 Å is deﬁned as the
critical length, the typical lifetime was on the order of ps. This is
orders of magnitude faster than the exchange of 5-HT between
membrane and bulk (see, e.g., Figure S7), and it follows that 5-
HT is mobile in the membrane interface and drifts between
diﬀerent lipid molecules. High mobility of, e.g., small aromatic
compounds has also been observed in 1H MAS NOESY NMR
studies.2
During the absorption of 5-HT, the molecule is dehydrated.
To monitor the eﬀect, we have calculated the hydration level of
5-HT (Table S1). As for the deﬁnition of the ﬁrst hydration
shell, we used a 3.5 Å cutoﬀ that corresponds to the ﬁrst
minimum in the oxygen−oxygen radial distribution function for
water.38 The cutoﬀ was applied for water molecules measured
from the water oxygen atom to the closest atom of 5-HT. As 5-
HT diﬀuses deeper into the bilayer, 5-HT loses ∼50% (5-HT+)
to ∼80% (5-HTn) of water molecules in the ﬁrst hydration
shell. Hence, 5-HT remains partially hydrated, and the largest
reduction in the hydration level is observed for 5-HTn. This is
not surprising since 5HTn is neutral and its alkyl chain enters
deeper into the bilayer than observed for 5-HT+.
Figure 5. Zoom-in of the probability distributions of minimum
distance, P(dmin), between Plipid and selected 5-HT atoms (N12, N22,
O4, and H5) extracted from the DPPC/5-HT+ (left), DOPC/5-HT+
(middle), and DPPC/5-HTn (right) systems. For 5-HT+, the most
important interaction is between Plipid and N225‑HT (P(dmin≈ 3.7 Å,
N225‑HT)maximum ≈ 0.8−0.9), followed by Plipid-H55‑HT (P(dmin ≈ 2.8 Å,
H55‑HT)maximum < ∼0.4) and Plipid-N125‑HT (P(dmin ≈ 3.7 Å,
N125‑HT)maximum < ∼0.3). No strong preference for Plipid was identiﬁed
for 5-HTn, as all investigated P(dmin)’ were around 0.1−0.2. P(dmin)’s
for 2 Å ≤ dmin ≤ 9 Å are provided in Figure S5.
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Eﬀect of Serotonin on Bilayer Structure. The structural
eﬀects of 5-HT absorption on the ordering of the alkyl chain
were assessed by calculating the order parameter SCD (deﬁned
in Supporting Information). The order proﬁles for the DPPC/
5-HT+,n and DOPC/5-HT+ systems are shown in Figure 6. For
comparison, the order parameter proﬁles for the pure bilayers
are also displayed. The absorption of 5-HT results in changes of
the structural ordering in the alkyl chains. These results are in
good agreement with the ﬁndings of Heimburg and co-workers,
who demonstrated that several classes of small molecules,
including neurotransmitters, aﬀect membrane properties,
resulting in broadening of the melting transition and in melting
point depression.52,77 For DPPC, 5-HT+ causes disorder mainly
in the region C12−C15. It appears that, in the C12−15 region,
5-HT+ disrupts the lipid structure more than 5-HTn. This is in
good agreement with the observation that the chain of 5-HTn
aligns with the phospholipid alkyl chain as the molecule
penetrates deeper into the bilayer. The feature of the order
parameter proﬁles for the DOPC/5-HT+ is signiﬁcantly
diﬀerent. Here, the largest eﬀect is seen between C10 and
C17, i.e., in the region beyond the double bond in the alkyl
chains. The order parameter for C12−C14 reduces by ∼0.08
when compared to that of the pure DOPC bilayer membrane.
■ CONCLUSION
5-HT was found to interact strongly with the investigated lipid
membranes, and the calculated partitioning coeﬃcient was
comparable to literature values for highly hydrophobic
compounds such as hexanol or heptanol. In contrast to these
molecules, 5-HT is a hydrophilic solute with a bulk oil−water
partitioning coeﬃcient far below unity. This implies that the
aﬃnity of 5-HT for lipid membranes involves direct
interactions with the lipid molecules. Such interactions were
investigated in the MD simulations, and it was found that
attraction between the (cationic) primary amine of 5-HT and
the lipid phosphate group constituted the main driving force.
This salt-bridge anchored one end of the 5-HT molecule, while
the other was pointing inward and typically located at the same
depth as the ester bonds of the lipid. The mobility of 5-HT in
this position was high, but its aﬃnity for lipids may have been
supplemented by hydrophobic eﬀects, as it was partially
dehydrated. The importance of the salt bridge was further
illustrated by a distinctive change in the mode of interaction
upon deprotonation of 5-HT. Thus, the neutral form turned
around so the primary amine points toward the membrane
core, and also moved to a slightly deeper average position.
Insertion of 5-HT (particularly the cationic form) into the
membrane interface decreased lipid chain ordering. This work
was motivated by recent suggestions of “non-speciﬁc” eﬀects of
serotonin in neural transmission (see Introduction), which rely
on the transmitter molecule’s interaction with the lipid matrix
of the synaptic membrane. Obviously, results from simple
model systems like the ones studied here can provide only
circumstantial evidence, but the distinctive aﬃnity for
membranes and the concomitant structural perturbation appear
to be necessary premises for membrane-based eﬀects of 5-HT
in general, and also in line with the two speciﬁc hypotheses
reiterated in the Introduction.
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